The researchers found that delphinidin's anti-diabetes mechanism with hypertension may be associated with its strong antioxidant activity, inhibiting α-glucossidase and α-amylase, angiotensin converting ase (ACE) and direct vascular relaxation or calcium channel regulation [19]. The gene discussed is ACE; the disease is hypertensive disorder.